MBIO
MUSTANG BIO, INC.Company Information
- Company Name
- MUSTANG BIO, INC.
- CIK
- CIK0001680048
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- MBIO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- MBIO
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-30
- Last sale
- 2025-12-30
- Shares purchased (TTM)
- 247
- Shares sold (TTM)
- 251
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 524,664
- Shares outstanding
- 6,732,970
- Ownership
- 7.79%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- -9.88%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Class A | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | ||||||
| Common Unspecified Class | 0 | 7 | 6 | 3 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 15 | 16 | 17 | 19 | 13 | 14 | 7 | 4 | 4 | 1 | 6 | 10 | ||||||
| Other Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 7 | 4 | 0 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | 0 | 0 | 0 | 0 | 1 | 2 | 2 | - | 0 | - | ||||||
| Assets Current | - | - | 18 | 19 | 13 | 15 | 9 | 6 | 7 | 9 | 11 | 14 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Property Plant And Equipment Net | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 3 | - | ||||||
| Other Assets Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | ||||||
| Assets | 16 | 17 | 18 | 19 | 13 | 15 | 9 | 7 | 9 | 15 | 18 | 21 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 5 | 5 | 5 | 7 | 8 | 8 | 9 | 12 | 13 | 15 | 14 | 13 | ||||||
| Other Liabilities Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | - | 1 | - | ||||||
| Operating Lease Liability Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | ||||||
| Liabilities Current | 8 | 8 | 8 | 9 | 10 | 11 | 13 | 15 | 16 | 17 | 15 | 14 | ||||||
| Deferred Income Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | ||||||
| Liabilities | 8 | 8 | 8 | 10 | 10 | 11 | 13 | 16 | 17 | 20 | 18 | 17 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Subscriptions | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | ||||||
| Additional Paid In Capital Common Stock | 408 | 408 | 408 | 408 | 401 | 400 | 392 | 387 | 386 | 381 | 381 | 376 | ||||||
| Retained Earnings Accumulated Deficit | -401 | -400 | -399 | -398 | -398 | -397 | -397 | -396 | -394 | -386 | -381 | -372 | ||||||
| Stockholders Equity | 8 | 9 | 10 | 10 | 3 | 4 | -4 | -9 | -8 | -5 | 0 | 4 | ||||||
| Liabilities And Stockholders Equity | 16 | 17 | 18 | 19 | 13 | 15 | 9 | 7 | 9 | 15 | 18 | 21 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Subscribed But Unissued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMUSTANG BIO, INC. (MBIO) — SEC Financial Statements & Analysis
MUSTANG BIO, INC. (MBIO) is a pharmaceutical preparations company, incorporated in DE. MUSTANG BIO, INC. trades on Nasdaq as: MBIO. MUSTANG BIO, INC. (MBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, MUSTANG BIO, INC. carries a market cap of $4.73M, a P/E ratio of -1.56x, a P/B ratio of 0.63x, an enterprise value of $-10.42M, and an EV/EBITDA multiple of 2.96x. On profitability, it posts a Return on Equity (ROE) of -58.12% and a Return on Assets (ROA) of -14.28%. Per share, it reports EPS of $-0.45, diluted EPS of $-0.45, free cash flow per share of $-0.67, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -7.45% year-over-year and EPS growth of -44.72% year-over-year. On the balance sheet, it maintains a current ratio of 2.22x, a quick ratio of 2.21x, working capital of $9.68M, a debt-to-equity ratio of 1.07x, a debt ratio of 0.46, an interest coverage ratio of -2779.00x, free cash flow of $-4.51M (TTM), and net debt of $-15.15M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.73M
- P/E TTM
- -1.56x
- EPS TTM
- $-0.45
- P/B TTM
- 0.63x
- ROE TTM
- -58.12%
- ROA TTM
- -14.28%
- Debt To Equity
- 1.07x
- Free Cash Flow TTM
- $-4.51M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MUSTANG BIO, INC. in?
MUSTANG BIO, INC. (MBIO) operates in the Pharmaceutical Preparations industry.
What exchange does MBIO trade on?
MUSTANG BIO, INC. (MBIO) trades on the Nasdaq.
Where is MUSTANG BIO, INC. incorporated?
MUSTANG BIO, INC. is incorporated in DE.
When was MUSTANG BIO, INC. (MBIO)'s most recent SEC filing?
MUSTANG BIO, INC. (MBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is MBIO's market cap?
MUSTANG BIO, INC. (MBIO) has a market capitalization of $4.73M as of 2026-06-30.
What is MBIO's EPS (earnings per share)?
MUSTANG BIO, INC. (MBIO)'s trailing twelve month EPS is $-0.45 as of 2026-06-30.
What is MBIO's ROE (return on equity)?
MUSTANG BIO, INC. (MBIO)'s trailing twelve month Return on Equity (ROE) is -58.12% as of 2026-06-30.
What is MBIO's ROA (return on assets)?
MUSTANG BIO, INC. (MBIO)'s trailing twelve month Return on Assets (ROA) is -14.28% as of 2025-12-31.
What is MBIO's EV/EBITDA?
MUSTANG BIO, INC. (MBIO)'s trailing twelve month EV/EBITDA is 2.96x as of 2026-06-30.